Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.

Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review

Open access

Abstract

Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive, neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor neuron degeneration and variable presentation in relation to onset and severity. A prevalence of approximately 1-2 per 100,000 persons and incidence around 1 in 10,000 live births have been estimated with SMA type I accounting for around 60% of all cases. Since SMA is a relatively rare condition, studies of its prevalence and incidence are challenging. Most published studies are outdated and therefore rely on clinical rather than genetic diagnosis. Furthermore they are performed in small cohorts in small geographical regions and only study European populations. In addition, the heterogeneity of the condition can lead to delays and difficulties in diagnosing the condition, especially outside of specialist clinics, and contributes to the challenges in understanding the epidemiology of the disease. The frequency of unaffected, heterozygous carriers of the SMN1 mutations appears to be higher among Caucasian and Asian populations compared to the Black (Sub-Saharan African ancestry) population. However, carrier frequencies cannot directly be translated into incidence and prevalence, as very severe (death in utero) and very mild (symptom free in adults) phenotypes carrying bi-allelic SMN1 mutations exist, and their frequency is unknown. More robust epidemiological data on SMA covering larger populations based on accurate genetic diagnosis or newborn screening would be helpful to support planning of clinical studies, provision of care and therapies and evaluation of outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13023-017-0671-8

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Most common SMA genotypes among non-carriers and carriers
Fig. 1 Most common SMA genotypes among non-carriers and carriersCC BY · PubMed Central
Fig. 2 Carrier frequency studies for SMA. The grey area represents the 95% confidence interval based on the average carrier frequency (0.019) of all individuals (except those from the isolated Muslim Israeli Arab village and the Schmiedeleut Hutterites). Small dots represent individual studies. In case studies seperated between groups, these are depicted as separate dots. Large symbols represent pooled estimates for different ethnical groups
Fig. 2 Carrier frequency studies for SMA. The grey area represents the 95% confidence interval based on the average carrier frequency (0.019) of all individuals (except those from the isolated Muslim Israeli Arab village and the Schmiedeleut Hutterites). Small dots represent individual studies. In case studies seperated between groups, these are depicted as separate dots. Large symbols represent pooled estimates for different ethnical groupsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 117 references

Research works printed but not linked: 2

  1. SPINRAZA® (Nusinersen) Approved in the European Union as First Treatment for Spinal Muscular Atrophy [ http://media.biogen.com/press-release/investor-relations/spinraza-nusinersen-approved-european-union-first-treatment-spinal- ].
  2. Ignatius J, Donner M. Epidemiology of childhood disorders (in Finnish). In: H L, editor. Lihastautien Kehittyvä Tutkimus Ja Hoito. Turku: Kiasma; 1989.

Cited by

See all 739

Metadata

Authors
Verhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmüller, H.
Affiliations
  • Newcastle University (GB)
  • Biogen (United States) (US)
Corresponding author
Lochmüller, Hanns
Venue
Orphanet Journal of Rare Diseases
Published
2017-07-04
Volume
12
Issue
1
Pages
124-124
ISSN
1750-1172 (ISSN-L)
OpenAlex
W2733659072
Cited by
739
References
117
Citations by year
2026: 82 · 2025: 108 · 2024: 125 · 2023: 91 · 2022: 90 · 2021: 91 · 2020: 63 · 2019: 45 · 2018: 33 · 2017: 2
FWCI
5.52
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Orphanet Journal of Rare Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
Biogen
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
spinal muscular atrophy, chromosome 5q, SMN1, prevalence, incidence, carrier frequency, heterozygous carriers, SMA type I, phenotypic heterogeneity, genetic diagnosis, newborn screening
MeSH terms
Chromosomes, Human, Pair 5, Female, Humans, Male, Muscular Atrophy, Spinal, Incidence, Prevalence, Survival of Motor Neuron 1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. https://app.cochat.ai/papers/10.1186/s13023-017-0671-8
The paper
Verhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmüller, H. (2017). Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-017-0671-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.